Skip to main content
Back
Watch Compare

WORK Medical Technology Group LTD

Data quality: 83%
WOK
NASDAQ Manufacturing Measuring & Analyzing Instruments
$1.17
▲ $0.01 (0.86%)
6 months return
—
Momentum
Neutral
ROE
-6.81%

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-6.81%
Above sector avg (-54.68%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
1.00
Above sector avg (0.30)
Current Ratio1.14
Interest CoverageN/A

Valuation

PE (TTM)
-1.40
Above sector avg (-1.49)
P/B Ratio0.12
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Generating 4.91 M in free cash flow

Price History

Financial Trends

Analyst Price Target

No analyst coverage available

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -6.81% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -1.07 M
ROE -6.81% ROA -3.09%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 4.91 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: 1.00 · Current: 1.14
Debt / Equity 1.00 Current Ratio 1.14
Interest Coverage N/A Asset Turnover N/A
Working Capital 2.60 M Tangible Book Value 11.97 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -1.40 · EV/EBITDA: N/A
P/E Ratio -1.40 Forward P/E N/A
P/B Ratio 0.12 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 326.74%
Market Cap 1.50 M Enterprise Value 12.39 M

Per Share

EPS: -0.04 · FCF/Share: 3.79
EPS (Diluted TTM) -0.04 Revenue / Share N/A
FCF / Share 3.79 OCF / Share 4.82
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -457.90% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion -457.90%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -1.07 M -3.49 M
EPS (Diluted) -0.04 -0.27
Gross Profit 2.34 M 2.87 M
Operating Income — —
EBITDA — —
R&D Expenses 435,311.0 302,511.0
SG&A Expenses — —
D&A 923,108.0 1.41 M
Interest Expense 503,519.0 557,571.0
Income Tax 119,053.0 -125,291.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 33.16 M 36.25 M
Total Liabilities 11.99 M 20.18 M
Shareholders' Equity 18.34 M 13.19 M
Total Debt 6.39 M 13.32 M
Cash & Equivalents 4.09 M 6.56 M
Current Assets 20.46 M 20.83 M
Current Liabilities 11.97 M 20.18 M

Peer Comparison

vs Manufacturing sector median (1605 peers)
Metric Stock Sector Median
P/E -1.4 -1.5
P/B 0.1 1.6
ROE % -6.8 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 1.0 0.3